HomeIndustriesBanks & FinanceBA's $3.5B Loss, NVO Weight Loss Drug Trial, AXP Down on Strong Earnings

BA's $3.5B Loss, NVO Weight Loss Drug Trial, AXP Down on Strong Earnings

"It's difficult to find what we're not liking" for American Express's (AXP) earnings, says Jenny Horne. A strong report bolstered by a big holiday shopping season wasn't enough to impress investors. Boeing (BA) gave its investors a heads up by noting a $3.5 billion cash flow loss for fourth quarter. Novo Nordisk (NVO) rallied after posting positive early-stage results for one of its weight loss drugs. Jenny takes a closer look into the market's reaction to these developing stories.

Morning Trade Live

24 Jan 2025

SHARE

ON AIR
education
2:30 am
Your First Trade
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
ON AIR
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor